How online GLP-1 services work
- Sign up and intake (10-30 min). You provide medical history, weight and height, comorbidities, current medications, allergies, and answer screening questions about contraindications.
- Synchronous video visit (15-30 min). A clinician licensed in your state — physician, nurse practitioner, or physician assistant — reviews your history, may ask follow-up questions, screens for contraindications, and decides whether GLP-1 is clinically appropriate.
- Labs, where indicated. Some platforms require baseline HbA1c, comprehensive metabolic panel, and lipid panel; others proceed based on clinical history. At-home or local lab draw options.
- Prescription decision (24-72 hours). If approved, prescription is sent to a partnered pharmacy.
- Medication ships (3-7 business days). Cold-chain shipping for injectables.
- Follow-up care. Most programs include scheduled check-ins, message-based clinician access, and dose titration support.
Total time from sign-up to first dose is typically about one week.
Legal basis for online prescribing
Telemedicine prescribing of non-controlled medications (which includes all GLP-1 receptor agonists) is permitted in all 50 states when:
- The clinician holds an active license to practice in the patient's state of residence.
- A clinician-patient relationship has been established. Most states recognize a synchronous video visit as sufficient.
- The prescription is medically appropriate based on the evaluation.
Asynchronous-only "prescribing" via questionnaire is restricted in many states and is generally not a robust standard of care. Reputable telehealth services use synchronous video visits.
Compounded GLP-1 prescribing has additional layers: federal compounding rules (sections 503A and 503B of the FD&C Act), FDA drug shortage status, and state pharmacy board rules. These restrict when a compounded version can substitute for a commercially available brand-name product.
Start an online GLP-1 evaluation
A licensed clinician can review your eligibility and explain the path that fits your situation.
Start My Online Visit →Sponsored link. We earn a commission when you sign up. Medical eligibility determined by licensed providers. Disclosure
Pros and cons vs in-person
| Factor | Online / Telehealth | In-person (PCP, weight clinic) |
|---|---|---|
| Time to first prescription | Often <1 week | Often 2-8 weeks (appointment waits) |
| Insurance use | Variable; many self-pay | Most likely to use insurance |
| Compounded option access | Common | Rare |
| Lifestyle and behavioral support | Limited | Often more integrated |
| Continuity with other care | Lower | Higher with established PCP |
| Clinical evaluation depth | Adequate for most cases | Generally more thorough |
| Convenience | Higher | Lower |
Evaluating a telehealth platform
Quality indicators to look for:
- Synchronous video visit (not asynchronous-only questionnaire).
- Licensed clinicians in your state — verify the state where you reside is supported.
- Transparent pharmacy partner, particularly for compounded options. A platform that will not name its pharmacy is a flag.
- USP <797> compliance and third-party testing for compounded products.
- API sourcing documentation for compounded preparations — semaglutide / tirzepatide should come from FDA-registered facilities.
- Clear written disclosure of side effects and contraindications before prescribing.
- Side effect management protocols — easy way to reach a clinician when issues arise.
- Reasonable cancellation policy — avoid platforms locking you into multi-month plans without medical justification.
- Transparent pricing — no hidden upgrade pressure.
What to watch out for
- No video visit. Questionnaire-only "evaluation" with same-day prescription is not a robust clinical pathway and is restricted in many states.
- "Compounded semaglutide" without disclosure of pharmacy. You should know who is making your medication.
- "Research peptide" suppliers selling vials. Not legitimate. Often labeled "not for human use." Risks include counterfeit, contamination, mislabeled salt forms.
- Multi-month prepayment with no exit clause. Reasonable platforms allow you to stop if the medication does not work for you.
- Excessive marketing claims. "Lose 30 pounds in 30 days" or "guaranteed weight loss" violates FDA and FTC standards.
- No FDA-approved option offered. A platform offering only compounded products with no path to brand-name is limited.
State-by-state considerations
- All 50 states allow telehealth prescribing of GLP-1 by appropriately licensed clinicians.
- A handful of states have moved to limit compounded GLP-1 medications independent of federal shortage status.
- Some states have specific telemedicine rules (Indiana, Texas, Tennessee, and others) that affect what platforms can offer.
- Reputable platforms publish state availability lists.
Bottom line
Online GLP-1 access via telehealth is legitimate, fast, and broadly available. The quality range among platforms is wide, so evaluate against the indicators above. If a service combines a synchronous video visit with a transparent pharmacy partner and reasonable terms, it can be the simplest path to evidence-based GLP-1 therapy. If a service skips the video visit, hides the pharmacy, or pushes unverified products, it is best avoided regardless of price.
Start an online evaluation
Licensed clinicians, synchronous video visit, transparent pharmacy partner. See if you qualify in minutes.
Check Your Eligibility →Sponsored link. We earn a commission when you sign up. Medical eligibility determined by licensed providers. Disclosure